alendronate and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine

alendronate has been researched along with 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cronstein, BN; Flatow, JS; Gao, ZG; Haraczy, AJ; Jacobson, KA; Larrañaga-Vera, A; Leucht, P; Mediero, A; Rao, H; Sussman, SM; Toti, KS; Warnick, E	1

Other Studies

1 other study(ies) available for alendronate and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine

Article	Year
Novel alendronate-CGS21680 conjugate reduces bone resorption and induces new bone formation in post-menopausal osteoporosis and inflammatory osteolysis mouse models. Arthritis research & therapy, 2022, 12-09, Volume: 24, Issue:1 Topics: Alendronate; Animals; Bone Resorption; Disease Models, Animal; Female; Humans; Mice; Mice, Inbred C57BL; Osteoclasts; Osteogenesis; Osteolysis; Osteoporosis, Postmenopausal; RANK Ligand	2022

Article

Year

Novel alendronate-CGS21680 conjugate reduces bone resorption and induces new bone formation in post-menopausal osteoporosis and inflammatory osteolysis mouse models.

Arthritis research & therapy, 2022, 12-09, Volume: 24, Issue:1

Topics: Alendronate; Animals; Bone Resorption; Disease Models, Animal; Female; Humans; Mice; Mice, Inbred C57BL; Osteoclasts; Osteogenesis; Osteolysis; Osteoporosis, Postmenopausal; RANK Ligand

2022